|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Income from continuing operations, net of tax | |||||
| Adjustments to income from continuing operations: | |||||
| Depreciation and amortization | |||||
| Equity-based compensation | |||||
| Asbestos-related benefit, net | |||||
| Deferred income tax expense (benefit) | |||||
| (Gain) loss on sale of businesses | |||||
| Loss (gain) on sale of long-lived assets | |||||
| Other non-cash charges, net | |||||
| Contribution to divest asbestos-related assets and liabilities | |||||
| Changes in assets and liabilities: | |||||
| Change in receivables | |||||
| Change in inventories | |||||
| Change in contract assets | |||||
| Change in contract liabilities | |||||
| Change in accounts payable | |||||
| Change in accrued expenses | |||||
| Change in income taxes | |||||
| Other, net | |||||
| Net Cash – Operating activities | |||||
| Investing Activities | |||||
| Capital expenditures | |||||
| Proceeds from government incentives | |||||
| Proceeds from sale of business | |||||
| Proceeds from sale of long-lived assets | |||||
| Acquisitions, net of cash acquired | |||||
| Payments to acquire interest in unconsolidated subsidiaries | |||||
| Other, net | |||||
| Net Cash – Investing activities | |||||
| Financing Activities | |||||
| Commercial paper, net borrowings | |||||
| Long-term debt issued, net of debt issuance costs | |||||
| Long-term debt repayments | |||||
| Share repurchases under repurchase plan | |||||
| Payments for taxes related to net share settlement of stock incentive plans | |||||
| Dividends paid | |||||
| Proceeds from issuance of common stock | |||||
| Other, net | |||||
| Net Cash – Financing activities | |||||
| Exchange rate effects on cash and cash equivalents | |||||
| Net cash from discontinued operations – operating activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents – beginning of year (includes restricted cash of $0.7, $0.7, and $0.7, respectively) | |||||
| Cash and cash equivalents – end of year (includes restricted cash of $0.8, $0.7, and $0.7, respectively) | |||||
| Supplemental Disclosures of Cash Flow and Non-Cash Information: | |||||
| Cash paid for Interest | |||||
| Cash paid for Income taxes, net of refunds received | |||||
| Capital expenditures included in accounts payable | |||||
Loading...